Why Subscribe?✅ Curated by Tommy Tang, a Director of Bioinformatics with 100K+ followers across LinkedIn, X, and YouTube✅ No fluff—just deep insights and working code examples✅ Trusted by grad students, postdocs, and biotech professionals✅ 100% free
Hello Bioinformatics lovers, Happy July 4th! If you celebrate it. We had two days off, so I enjoyed staying at home reading books. The best way to learn something new is by reading. Then apply what you read to a practical problem. Repeat, practice. You will find a better version of yourself in 10 years! I had a conversation on a podcast talking about AI and bioinformatics. Hope you enjoy it! Today, we will talk about single-cell studies. How many cells are needed? Another single-cell study drops. But here’s the question: Single-cell technology was a game-changer. What is worth debating is what we’re actually doing with this power. Most headlines? “Cancer is heterogeneous.” Sure. But that’s not new. We’re stuck in a cell-counting arms race: But after a certain point, more cells ≠ better insight. Too many studies stay in “descriptive mode”:
It looks impressive—until you ask what it all means. The real prize?
The best single-cell work doesn’t just map cell types.
Let’s stop equating "more cells" with "better science."
The next frontier isn’t deeper sequencing. Not just more resolution—more relevance. So the next time you read a single-cell study, ask:
Because the story isn't that tumors are complex. If this resonates, share it with a colleague who's swimming in UMAP plots. Other posts that you may find useful:
PS: If you want to learn Bioinformatics, there are other ways that I can help:
Stay awesome! |
Why Subscribe?✅ Curated by Tommy Tang, a Director of Bioinformatics with 100K+ followers across LinkedIn, X, and YouTube✅ No fluff—just deep insights and working code examples✅ Trusted by grad students, postdocs, and biotech professionals✅ 100% free